Treatment patterns, outcomes and health care resource utilisation in patients with metastatic renal cell carcinoma (RCC)
- Conditions
- Metastatic renal cell carcinoma
- Registration Number
- JPRN-UMIN000043018
- Lead Sponsor
- MSD K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 1000
Not provided
a.Patient who have any active cancer or undergoing treatment for cancer other than mRCC b.Patient received/about to receive 1L systemic anti-cancer treatment as a clinical trial participant. c.Patient's last adjuvant treatment for RCC was less than 4 weeks (i.e. 28 days) d.Investigator determined the patient to be ineligible due to incomplete medical records at the time of enrolment. Incomplete medical records might be observed for patients who recently transferred to the site without diagnosis or treatment records, or for patients who attended the site only for consultation or second opinion. e.Patients those can be treated with curative intent through either surgical resection and/or percutaneous local therapy will be excluded. a.Patients with transitional cell carcinoma of the renal pelvis or ureter
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method